More than 8,000 procedures later, padded packages are on the rise, despite potential risks and a reputation rooted in ...
Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a hormone called glucose-dependent insulinotropic polypeptide (GIP) to “help break ...
An ongoing phase 2 trial (NCT07222579) has seen early success with a new subcutaneous formulation of blinatumomab (Blincyto) in a patient with CD19-positive mixed phenotype acute leukemia (MPAL), a ...
The agent, first approved in December for biweekly subcutaneous injection for EGFR-mutated NSCLC, showed similar efficacy and safety when administered monthly.
In this footage, this majestic big cat is hanging by a rope as they attempt to eat a tasty watermelon. At first, this might seem like a stunt or some kind of Spider-Man spectacle, but it’s really just ...
A couple's first act of marriage was rescuing an injured bird. United Kingdom-based couple Erica and Bob Nash said "I do" at Skipton Registration Office in England, on Saturday, Jan. 31, according to ...
From nutritional nuggets to fat-burning workouts, here are 10 ways to lose your belly and shed some timber without reducing ...
Halozyme Therapeutics (HALO) has reportedly spent up to $1.3 billion in acquiring three biotech startups in recent months.
The development, researchers say, could fundamentally change how hypertension is managed, particularly at a time when control rates remain alarmingly low.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results